Cambridge, MA, United States of America

Run-Ming David Wang

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 8.8

ph-index = 4

Forward Citations = 84(Granted Patents)


Location History:

  • Somerville, MA (US) (2008 - 2011)
  • Cambridge, MA (US) (2011 - 2013)

Company Filing History:


Years Active: 2008-2013

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovative Contributions of Run-Ming David Wang in Cancer Treatment

Introduction: Run-Ming David Wang is a distinguished inventor located in Cambridge, MA, whose contributions to the field of pharmaceuticals have led to the grant of nine patents. His work primarily focuses on developing innovative compounds that target proliferative diseases such as cancer, showcasing his commitment to advancing medical science and improving patient outcomes.

Latest Patents: Among his latest patents are two significant inventions. The first patent is for (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof, which is useful in treating various proliferative diseases, including cancer. The second patent pertains to SMAC peptidometics that function as IAP (Inhibitor of Apoptosis Protein) inhibitors, also targeting cancer treatment through specific biochemical pathways. Both inventions highlight his innovative approach in the pharmaceutical industry.

Career Highlights: Run-Ming David Wang has made significant strides in his career, particularly as an inventor at Novartis AG. His dedication to research and development has not only resulted in a portfolio of patents but also a reputation for excellence in pharmaceutical innovations aimed at combating serious health challenges.

Collaborations: Throughout his career, Run-Ming has collaborated with notable coworkers, including Christopher Sean Straub and Leigh Zawel. These collaborations have likely played a crucial role in fostering a creative environment that promotes the exchange of ideas, leading to groundbreaking inventions and advancements in their respective fields.

Conclusion: Run-Ming David Wang's contributions to the field of cancer treatment through his innovative patents have established him as a significant figure in pharmaceutical research. His dedication to developing effective treatments reflects the importance of innovation in enhancing healthcare solutions, making him a valuable asset to Novartis AG and the broader medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…